Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Change in Acquisitions & Divestments: 2011-2024

Historic Change in Acquisitions & Divestments for Ptc Therapeutics (PTCT) over the last 13 years, with Dec 2024 value amounting to $549.6 million.

  • Ptc Therapeutics' Change in Acquisitions & Divestments rose 14.93% to $177.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $683.1 million, marking a year-over-year increase of 70.13%. This contributed to the annual value of $549.6 million for FY2024, which is 315.65% up from last year.
  • Ptc Therapeutics' Change in Acquisitions & Divestments amounted to $549.6 million in FY2024, which was up 315.65% from $132.2 million recorded in FY2023.
  • In the past 5 years, Ptc Therapeutics' Change in Acquisitions & Divestments registered a high of $944.1 million during FY2020, and its lowest value of $132.2 million during FY2023.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $405.2 million (2022), whereas its average is $362.4 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first soared by 504.14% in 2020, then crashed by 67.37% in 2023.
  • Over the past 5 years, Ptc Therapeutics' Change in Acquisitions & Divestments (Yearly) stood at $944.1 million in 2020, then fell by 10.66% to $843.5 million in 2021, then tumbled by 51.96% to $405.2 million in 2022, then plummeted by 67.37% to $132.2 million in 2023, then spiked by 315.65% to $549.6 million in 2024.